Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Fascioliasis

Below is an extended Fascioliasis patents listing. Click here to return to the Fascioliasis main in depth entry.

Patents :

US Patent No.Title
7276509 Piperidine derivatives and their use as antagonists of tachykinins
7368527 HADDE71 polypeptides
7368531 Human secreted proteins
7381800 Antibodies to HBIMF63 polypeptide
7381826 Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4- -yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone
7405212 Helix mimetics and composition and methods related thereto
7407952 Reverse-turn mimetics and compositions and methods related thereto
7407959 Cathepsin cysteine protease inhibitors
7410970 Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7411051 Antibodies to HDPPA04 polypeptide
7427630 Condensed N-heterocyclic compounds and their use as CRF receptor antagonists
7368432 Conotoxin peptides
7358278 Cellular phosphorylation potential enhancing compositions preparation and use thereof
7279474 Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF)
7294630 Piperazinyl piperidine tachykinin antagonists
7312353 Cathespin cysteine protease inhibitors
7320994 Triazole derivatives as tachykinin receptor antagonists
7329667 CRF receptor antagonists
7342028 Medical use for tachykinin antagonists
7345040 Reverse-turn mimetics and compositions and methods relating thereto
7345041 Chemical compounds
7345083 Hydroisoindoline tachykinin receptor antagonists
7351861 Method and probe for identifying bacterial virulence modifying agents, agents thus identified, and their use
7432046 Methods for the determination of antibody IgG avidity
7435736 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
7459531 50 Human secreted proteins
7544694 Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists
7544815 Process for making hydroisoindoline tachykinin receptor antagonists
7547804 Compounds, compositions, and methods employing same
7553816 p-amidobenzylethers in drug delivery agents
7553861 Dipeptidyl peptidase-IV inhibitors
7569384 Albumin fusion proteins
7572786 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists
7592010 Albumin fusion proteins
7595160 Analyte detection using barcoded polymers
7601355 Compositions and methods for altering immune function
7534893 Imidazol-2-one compounds useful in the treatment of various disorders
7534437 Helminth-derived antigens having capacity of providing protection against parasites
7462622 Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
7468437 Phenyl pyrrolidine ether tachykinin receptor antagonists
7482013 Albumin fusion proteins
7482365 Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
7498298 Monomethylvaline compounds capable of conjugation to ligands
7507413 Albumin fusion proteins
7507414 Albumin fusion proteins
7514079 Antibodies that specifically bind to neurokinin B
7514424 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists
7521424 Albumin fusion proteins
7612056 Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.